Today’s clinical studies are more complex and involve more critical systems than ever before. They require close integration to minimize human error and maximize efficiency.

For studies involving randomization, interactive response technology (IRT) is a critical component ensuring participants receive the correct study drug to authenticate the study hypothesis. Randomization and decentralized trials are well-suited to work together to provide the required information to the study and site personnel, especially when working with a remote team.

This webinar focuses on how IRT integration can positively affect:

• Randomizing with minimal site interaction
• Minimizing duplication of data
• Managing the re-screen process
• Managing the re-consent process
• Managing dispensation